Related Experiment Video
Updated: Mar 19, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
MiR-367 negatively regulates apoptosis induced by adriamycin in osteosarcoma cells by targeting KLF4
Guang-Chao Wang1, Qian-Yun He1, Da-Ke Tong1
1Department of Orthopedics, Changhai Hospital, The Second Military Medical University, 168 Changhai Road, Shanghai 200433, China.
Abstract:
Diverse functions of microRNAs have been investigated in tumorigenesis in osteosarcoma (OS), involving the regulation of proliferation, invasion, migration, apoptosis and drug resistance. MiR-367 was found to be an oncogene and increased in OS. However, the function of miR-367 in drug resistance in OS cells is still unknown. In this study, we found that miR-367 was up-regulated in OS tissues and OS cell cultures. Meanwhile, treatment with adriamycin (ADR) induced apoptosis of OS cells with upregulation of miR-367. Notably, KLF4 was demonstrated to be a direct target of miR-367 by gene reporter assay, and miR-367 significantly blocked both mRNA and protein level of KLF4. In addition, overexpression of miR-367 markedly suppressed the increase of KLF4 induced by ADR in OS cells, as well as Bax and cleaved caspase-3, which were significantly reversed by anti-miR-367 transfection. Taken together, our data demonstrates that miR-367 and KLF4 play important roles in OS treatment and ADR resistance, suggesting that miR-367 is a potential biomarker of chemotherapy resistance in OS and also probably a novel therapeutic target against OS.
Insights
MicroRNA-367 (miR-367) is elevated in osteosarcoma and contributes to adriamycin (ADR) resistance by downregulating KLF4. This suggests miR-367 is a potential biomarker and therapeutic target for osteosarcoma chemotherapy resistance.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- MicroRNAs (miRNAs) play diverse roles in osteosarcoma (OS) tumorigenesis, including regulating proliferation, invasion, migration, apoptosis, and drug resistance.
- MiR-367 is identified as an oncogene and is frequently upregulated in OS.
- The specific role of miR-367 in mediating drug resistance in OS cells remains largely unexplored.
Purpose of the Study:
- To investigate the function of miR-367 in adriamycin (ADR) resistance in osteosarcoma (OS) cells.
- To identify the molecular mechanisms underlying miR-367's role in OS drug resistance.
- To evaluate the potential of miR-367 as a biomarker and therapeutic target for OS chemotherapy.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) to measure miR-367 expression in OS tissues and cell lines.
- Western blot analysis to assess protein levels of KLF4, Bax, and cleaved caspase-3.
- Luciferase reporter assay to confirm KLF4 as a direct target of miR-367.
- Transfection with miR-367 mimics and inhibitors (anti-miR-367) to manipulate miR-367 levels in OS cells.
Main Results:
- MiR-367 expression was significantly upregulated in OS tissues and cell lines.
- Adriamycin (ADR) treatment induced apoptosis in OS cells and concurrently upregulated miR-367.
- KLF4 was confirmed as a direct target of miR-367, with miR-367 negatively regulating KLF4 expression at both mRNA and protein levels.
- Overexpression of miR-367 suppressed ADR-induced KLF4 upregulation and apoptosis-related proteins (Bax, cleaved caspase-3), effects reversed by anti-miR-367.
- Conversely, anti-miR-367 transfection reversed the effects of miR-367 overexpression on KLF4 and apoptosis markers.
Conclusions:
- MiR-367 plays a crucial role in mediating adriamycin (ADR) resistance in osteosarcoma (OS) by targeting KLF4.
- The miR-367/KLF4 axis influences apoptosis pathways in OS cells.
- MiR-367 represents a potential biomarker for predicting chemotherapy resistance in OS and a promising therapeutic target for overcoming drug resistance.
More Related Videos
10:09Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
MicroRNAs
Abnormal Proliferation